Voyageur Pharmaceuticals Ltd (VM) — Capital Reinvestment Ratio

Latest as of November 2023: 1.12x

Voyageur Pharmaceuticals Ltd (VM) has a Capital Reinvestment Ratio of 1.12x as of November 2023, meaning it reinvests 1% of its operating cash flow (CA$29.56K) in capital expenditures (CA$33.21K). See debt-free asset ratio of Voyageur Pharmaceuticals Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.12x
Capex / Operating Cash Flow

Operating Cash Flow

CA$29.56K
CAD

Capital Expenditures

CA$33.21K
CAD

Data as of

Nov 2023
Most recent filing

Annual Capital Reinvestment Ratio for Voyageur Pharmaceuticals Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Voyageur Pharmaceuticals Ltd from None to None. For live market cap and broader valuation context, see VM market cap overview.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow